/Investor DB

Flyover Capital — 2025 Investments

2 investments dated 2025 · listed companies and verified rows first · show all

Triallytrially.aiinSeed · Aug 2025 · $4.7M

Trially uses AI and data science to match patients with clinical trials and accelerate trial recruitment.

AI & Machine LearningDigital HealthHealthtechMedical DevicesKansas City, US

Kyle McAllister(CEO & Founder)inTrevor Welch(Executive Officer, Director)in

Board seatThad Langford· per SEC Form D

Co-investorsAlpaca VCCorigin VenturesGaingelsRedbud VCThe CouncilAtria Ventures+2 more

Mavvrikmavvrik.aiFeb 2025

Mavvrik provides a platform for real-time financial control and cost management across cloud, on-premise, and AI spending.

AI & Machine LearningCloud ComputingEnterprise SoftwareSaaSAustin, US

Darmawan Suwirya(Founder)inPaul Franz(Founder)in

Co-investorsAmplify.LAKnoll VenturesS3 VenturesTech Square VenturesTuesday Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.